Northern Trust’s Phathom Pharmaceuticals PHAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.45M Sell
359,324
-27,299
-7% -$262K ﹤0.01% 2688
2025
Q1
$2.42M Sell
386,623
-11,341
-3% -$71.1K ﹤0.01% 2817
2024
Q4
$3.23M Buy
397,964
+77,189
+24% +$627K ﹤0.01% 2766
2024
Q3
$5.8M Buy
320,775
+44,115
+16% +$798K ﹤0.01% 2394
2024
Q2
$2.85M Sell
276,660
-6,540
-2% -$67.4K ﹤0.01% 2712
2024
Q1
$3.01M Sell
283,200
-6,619
-2% -$70.3K ﹤0.01% 2760
2023
Q4
$2.65M Buy
289,819
+21,043
+8% +$192K ﹤0.01% 2843
2023
Q3
$2.79M Buy
268,776
+51,590
+24% +$535K ﹤0.01% 2759
2023
Q2
$3.11M Buy
217,186
+4,285
+2% +$61.4K ﹤0.01% 2761
2023
Q1
$1.52M Buy
212,901
+1,852
+0.9% +$13.2K ﹤0.01% 3060
2022
Q4
$2.37M Buy
211,049
+19,340
+10% +$217K ﹤0.01% 2911
2022
Q3
$2.12M Buy
191,709
+1,821
+1% +$20.2K ﹤0.01% 2985
2022
Q2
$1.6M Buy
189,888
+11,078
+6% +$93.5K ﹤0.01% 3174
2022
Q1
$2.43M Sell
178,810
-9,095
-5% -$124K ﹤0.01% 3004
2021
Q4
$3.7M Buy
187,905
+1,829
+1% +$36K ﹤0.01% 2888
2021
Q3
$5.97M Sell
186,076
-8,800
-5% -$282K ﹤0.01% 2619
2021
Q2
$6.6M Buy
194,876
+63,020
+48% +$2.13M ﹤0.01% 2659
2021
Q1
$4.95M Buy
131,856
+535
+0.4% +$20.1K ﹤0.01% 2749
2020
Q4
$4.36M Sell
131,321
-1,127
-0.9% -$37.4K ﹤0.01% 2759
2020
Q3
$4.86M Sell
132,448
-11,005
-8% -$404K ﹤0.01% 2549
2020
Q2
$4.72M Buy
143,453
+12,195
+9% +$401K ﹤0.01% 2562
2020
Q1
$3.39M Buy
131,258
+16,832
+15% +$435K ﹤0.01% 2530
2019
Q4
$3.56M Buy
+114,426
New +$3.56M ﹤0.01% 2789